Everstar Asset Management LLC Makes New $792,000 Investment in Zoetis Inc. $ZTS

Everstar Asset Management LLC acquired a new stake in Zoetis Inc. (NYSE:ZTS) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 11,025 shares of the company’s stock, valued at approximately $792,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in Zoetis by 12.9% during the 4th quarter. Vanguard Group Inc. now owns 47,780,974 shares of the company’s stock worth $6,011,802,000 after purchasing an additional 5,474,210 shares in the last quarter. J. Stern & Co. LLP raised its position in Zoetis by 12,431.2% in the 4th quarter. J. Stern & Co. LLP now owns 24,069,492 shares of the company’s stock valued at $3,028,423,000 after purchasing an additional 23,877,416 shares in the last quarter. State Street Corp raised its position in Zoetis by 0.8% in the 4th quarter. State Street Corp now owns 19,796,891 shares of the company’s stock valued at $2,490,845,000 after purchasing an additional 149,382 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Zoetis by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 11,327,679 shares of the company’s stock valued at $1,420,294,000 after buying an additional 189,235 shares during the period. Finally, Norges Bank purchased a new position in shares of Zoetis in the 4th quarter valued at about $734,425,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Argus reissued a “hold” rating on shares of Zoetis in a research report on Wednesday, May 27th. Citigroup reduced their target price on shares of Zoetis from $112.00 to $96.00 and set a “buy” rating on the stock in a report on Tuesday. Zacks Research downgraded shares of Zoetis from a “hold” rating to a “strong sell” rating in a research note on Monday, August 10th. William Blair reiterated a “market perform” rating on shares of Zoetis in a report on Thursday, August 6th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Zoetis from $130.00 to $115.00 and set an “overweight” rating on the stock in a research report on Friday, August 7th. Eight research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $109.62.

Zoetis Stock Down 2.9%

Shares of NYSE ZTS opened at $73.64 on Friday. The business has a 50-day moving average of $76.30 and a two-hundred day moving average of $99.01. The company has a market capitalization of $30.43 billion, a price-to-earnings ratio of 12.13, a price-to-earnings-growth ratio of 1.31 and a beta of 0.74. Zoetis Inc. has a 1 year low of $71.45 and a 1 year high of $160.48. The company has a debt-to-equity ratio of 2.87, a current ratio of 3.08 and a quick ratio of 1.84.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.87 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.02. Zoetis had a return on equity of 74.89% and a net margin of 27.49%.The business had revenue of $2.47 billion for the quarter, compared to the consensus estimate of $2.50 billion. During the same quarter in the prior year, the business posted $1.76 EPS. The business’s revenue for the quarter was down .2% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. On average, analysts forecast that Zoetis Inc. will post 6.19 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Monday, July 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.9%. The ex-dividend date is Monday, July 20th. Zoetis’s dividend payout ratio is currently 34.93%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.